Impact of estrogen therapy on health issues in postmenopausal women with HIV
Effect of estrogen replacement on postmenopausal ART-associated comorbidity and viral latency
This study is looking at how estrogen replacement therapy might help improve health issues related to aging, like weight gain and diabetes, in women living with HIV after menopause, to find better ways to support their overall health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11076821 on NIH RePORTER |
What this research studies
This research investigates how estrogen replacement therapy may affect health complications associated with aging in women living with HIV, particularly after menopause. It focuses on understanding the relationship between estrogen deficiency and various age-related diseases, such as obesity and diabetes, in this population. The study aims to explore how estrogen therapy could potentially improve metabolic health and reduce chronic inflammation linked to antiretroviral therapy. By examining these factors, the research seeks to provide insights into better management strategies for postmenopausal women with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are postmenopausal women living with HIV who are experiencing age-associated health complications.
Not a fit: Patients who are not postmenopausal or those who do not have HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for postmenopausal women living with HIV by addressing age-related health issues.
How similar studies have performed: Previous research has shown promising results in addressing age-related health issues in women with HIV, but this specific approach focusing on estrogen therapy is relatively novel.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Kievit, Paul — Oregon Health & Science University
- Study coordinator: Kievit, Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.